Intigree Biomed Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.14 Cr
- Company Age 9 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.91 Cr
- Revenue Growth 255.41%
- Profit Growth 83.01%
- Ebitda 1663.01%
- Net Worth -117.40%
- Total Assets 15.60%
About Intigree Biomed
Intigree Biomed Private Limited (IBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 February 2016 (Nine years 22 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.14 Cr.
The company currently has active open charges totaling ₹3.91 Cr.
Archana Kulkarni and Aneesh Suhas serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233MH2016PTC272554
- Company No.
272554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Intigree Biomed?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Kulkarni  | Director | 02-Feb-2016 | Current |
| Aneesh Suhas | Director | 02-Feb-2016 | Current |
Financial Performance of Intigree Biomed.
Intigree Biomed Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 255.41% increase. The company also saw a substantial improvement in profitability, with a 83.01% increase in profit. The company's net worth observed a substantial decline by a decrease of 117.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intigree Biomed?
In 2021, Intigree Biomed had a promoter holding of 91.23% and a public holding of 8.77%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Sanatan Vishwagurupeeth FoundationAneesh Suhas is a mutual person
Charges (Loans)
₹3.91 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.91 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2024 | State Bank Of India | ₹2.20 M | Open |
| 31 Aug 2017 | State Bank Of India | ₹3.69 Cr | Open |
How Many Employees Work at Intigree Biomed?
Intigree Biomed has a workforce of 31 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intigree Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intigree Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
